APRE - CIK 0001781983
Aprea Therapeutics, Inc. has filed 425 documents with the SEC between 2019 and 2026. The most frequent type is insider trade (144 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2024-08-12 | 2024-08-12 |
| Quarterly report | 10-Q | 2024-08-12 | 2024-06-30 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Major company event | 8-K | 2024-06-20 | 2024-06-20 |
| Major company event | 8-K | 2024-06-17 | 2024-06-17 |
| Major company event | 8-K | 2024-05-14 | 2024-05-14 |
| Quarterly report | 10-Q | 2024-05-14 | 2024-03-31 |
| Insider trade | 4 | 2024-05-02 | 2024-05-01 |
| New insider ownership | 3 | 2024-05-02 | 2024-05-01 |
| 424B3 | - | 2024-04-30 | - |
| EFFECT | - | 2024-04-29 | - |
| Annual report to shareholders | ARS | 2024-04-25 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-25 | - |
| Proxy statement | DEF 14A | 2024-04-25 | 2024-06-20 |
| Company correspondence | CORRESP | 2024-04-25 | - |
| Major company event | 8-K | 2024-04-10 | 2024-04-10 |
| SEC correspondence | UPLOAD | 2024-04-08 | - |
| Securities registration | S-3 | 2024-04-03 | - |
| Insider trade | 4 | 2024-03-28 | 2024-03-28 |
| Insider trade | 4 | 2024-03-28 | 2024-03-28 |
| Major company event | 8-K | 2024-03-26 | 2024-03-26 |
| Annual report | 10-K | 2024-03-26 | 2023-12-31 |
| Insider trade | 4 | 2024-03-14 | 2024-03-13 |
| Insider trade | 4 | 2024-03-14 | 2024-03-13 |
| Insider trade | 4 | 2024-03-14 | 2024-03-13 |
| Insider trade | 4 | 2024-03-14 | 2024-03-13 |
| Major company event | 8-K | 2024-03-12 | 2024-03-11 |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| 424B3 | - | 2024-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-07 | - |
| Major company event | 8-K | 2024-02-06 | 2024-02-06 |
| 424B3 | - | 2024-02-05 | - |
| EFFECT | - | 2024-02-02 | - |
| Major company event | 8-K | 2024-02-02 | 2024-02-02 |
| Company correspondence | CORRESP | 2024-01-31 | - |
| SEC correspondence | UPLOAD | 2024-01-30 | - |
| Major company event | 8-K | 2024-01-26 | 2024-01-26 |
| Securities registration | S-3 | 2024-01-26 | - |
| Major company event | 8-K | 2024-01-04 | 2024-01-04 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| Employee stock plan | S-8 | 2023-11-09 | - |
| Major company event | 8-K | 2023-10-16 | 2023-10-16 |
| Major company event | 8-K | 2023-10-13 | 2023-10-13 |
| Major company event | 8-K | 2023-09-11 | 2023-09-11 |